O	0	1	c	c	SYM	O
O	1	2	-	-	:	O
O	2	5	Met	Met	NN	B-NP
O	6	16	expression	expression	NN	I-NP
O	17	19	is	be	VBZ	B-VP
O	20	29	regulated	regulate	VBN	I-VP
O	30	32	by	by	IN	B-PP
O	33	37	Mitf	Mitf	NNP	B-NP
O	38	40	in	in	IN	B-PP
O	41	44	the	the	DT	B-NP
B-Cell	45	55	melanocyte	melanocyte	NN	I-NP
I-Cell	56	63	lineage	lineage	NN	I-NP
O	63	64	.	.	.	O

O	66	76	Hepatocyte	Hepatocyte	NN	B-NP
O	77	83	growth	growth	NN	I-NP
O	84	90	factor	factor	NN	I-NP
O	91	92	(	(	(	O
O	92	95	HGF	HGF	NN	B-NP
O	95	96	)	)	)	O
O	96	97	/	/	SYM	B-NP
O	97	98	c	c	NN	I-NP
O	98	99	-	-	HYPH	B-NP
O	99	102	Met	Met	NN	I-NP
O	103	112	signaling	signaling	NN	I-NP
O	113	115	is	be	VBZ	B-VP
O	116	123	thought	think	VBN	I-VP
O	124	126	to	to	TO	I-VP
O	127	129	be	be	VB	I-VP
O	130	131	a	a	DT	B-NP
O	132	135	key	key	JJ	I-NP
O	136	143	pathway	pathway	NN	I-NP
O	144	146	in	in	IN	B-PP
O	147	151	both	both	CC	O
B-Cell	152	162	melanocyte	melanocyte	NN	B-NP
O	163	174	development	development	NN	I-NP
O	175	178	and	and	CC	O
B-Cancer	179	187	melanoma	melanoma	NN	B-NP
O	188	198	metastasis	metastasis	NN	I-NP
O	198	199	.	.	.	O

O	200	204	Here	Here	RB	B-ADVP
O	204	205	,	,	,	O
O	206	209	HGF	HGF	NN	B-NP
O	210	221	stimulation	stimulation	NN	I-NP
O	222	224	of	of	IN	B-PP
B-Cell	225	236	melanocytes	melanocyte	NNS	B-NP
O	237	240	was	be	VBD	B-VP
O	241	245	seen	see	VBN	I-VP
O	246	248	to	to	TO	B-VP
O	249	251	up	up	RB	I-VP
O	251	252	-	-	HYPH	I-VP
O	252	260	regulate	regulate	VB	I-VP
O	261	262	c	c	NN	B-NP
O	262	263	-	-	HYPH	O
O	263	266	Met	Met	NN	B-NP
O	267	277	expression	expression	NN	I-NP
O	277	278	.	.	.	O

O	279	281	In	In	IN	B-PP
O	282	284	an	an	DT	B-NP
O	285	291	effort	effort	NN	I-NP
O	292	294	to	to	TO	B-VP
O	295	303	decipher	decipher	VB	I-VP
O	304	307	the	the	DT	B-NP
O	308	317	mechanism	mechanism	NN	I-NP
O	318	320	by	by	IN	B-PP
O	321	326	which	which	WDT	B-NP
O	327	330	HGF	HGF	NN	B-VP
O	331	333	up	up	RB	B-ADVP
O	333	334	-	-	HYPH	B-NP
O	334	343	regulates	regulate	VBZ	B-VP
O	344	347	its	its	PRP$	B-NP
O	348	356	receptor	receptor	NN	I-NP
O	356	357	,	,	,	O
O	358	360	we	we	PRP	B-NP
O	361	366	found	find	VBD	B-VP
O	367	371	that	that	IN	B-SBAR
O	372	373	c	c	NN	B-NP
O	373	374	-	-	HYPH	O
O	374	377	Met	Met	NN	B-NP
O	378	380	is	be	VBZ	B-VP
O	381	382	a	a	DT	B-NP
O	383	389	direct	direct	JJ	I-NP
O	390	405	transcriptional	transcriptional	JJ	I-NP
O	406	412	target	target	NN	I-NP
O	413	415	of	of	IN	B-PP
O	416	420	Mitf	Mitf	NNP	B-NP
O	420	421	.	.	.	O

O	422	426	This	This	DT	B-NP
O	427	430	was	be	VBD	B-VP
O	431	440	confirmed	confirm	VBN	I-VP
O	441	445	with	with	IN	B-PP
B-Cellular_component	446	455	chromatin	chromatin	NN	B-NP
O	456	475	immunoprecipitation	immunoprecipitation	NN	I-NP
O	476	487	experiments	experiment	NNS	I-NP
O	488	490	of	of	IN	B-PP
O	491	494	the	the	DT	B-NP
O	495	500	human	human	JJ	I-NP
O	501	502	c	c	NN	I-NP
O	502	503	-	-	HYPH	I-NP
O	503	506	Met	Met	NN	I-NP
O	507	515	promoter	promoter	NN	I-NP
O	515	516	,	,	,	O
O	517	519	as	as	RB	B-CONJP
O	520	524	well	well	RB	I-CONJP
O	525	527	as	as	IN	I-CONJP
O	528	530	by	by	IN	B-PP
O	531	534	the	the	DT	B-NP
O	535	542	ability	ability	NN	I-NP
O	543	545	of	of	IN	B-PP
O	546	558	adenovirally	adenovirally	RB	B-NP
O	559	568	expressed	express	VBN	I-NP
O	569	573	Mitf	Mitf	NNP	I-NP
O	574	576	to	to	TO	B-VP
O	577	585	modulate	modulate	VB	I-VP
O	586	596	endogenous	endogenous	JJ	B-NP
O	597	598	c	c	NN	I-NP
O	598	599	-	-	HYPH	B-NP
O	599	602	Met	Met	NN	I-NP
O	603	610	protein	protein	NN	I-NP
O	611	617	levels	level	NNS	I-NP
O	618	620	in	in	IN	B-PP
B-Cell	621	632	melanocytes	melanocyte	NNS	B-NP
O	632	633	.	.	.	O

O	634	644	Disruption	Disruption	NN	B-NP
O	645	647	of	of	IN	B-PP
O	648	652	Mitf	Mitf	NNP	B-NP
O	653	660	blocked	block	VBD	B-VP
O	661	664	HGF	HGF	NN	B-NP
O	664	665	-	-	HYPH	B-NP
O	665	674	dependent	dependent	JJ	I-NP
O	675	684	increases	increase	NNS	I-NP
O	685	687	in	in	IN	B-PP
O	688	698	endogenous	endogenous	JJ	B-NP
O	699	700	c	c	NN	I-NP
O	700	701	-	-	HYPH	B-NP
O	701	704	Met	Met	NN	I-NP
O	705	712	message	message	NN	I-NP
O	713	716	and	and	CC	I-NP
O	717	724	protein	protein	NN	I-NP
O	725	731	levels	level	NNS	I-NP
O	731	732	,	,	,	O
O	733	743	indicating	indicate	VBG	B-VP
O	744	748	that	that	IN	B-SBAR
O	749	752	HGF	HGF	NN	B-NP
O	753	762	regulates	regulate	VBZ	B-VP
O	763	766	its	its	PRP$	B-NP
O	767	770	own	own	JJ	I-NP
O	771	779	receptor	receptor	NN	I-NP
O	780	786	levels	level	NNS	I-NP
O	787	790	via	via	IN	B-PP
O	791	795	Mitf	Mitf	NNP	B-NP
O	795	796	.	.	.	O

O	797	804	Finally	Finally	RB	B-ADVP
O	804	805	,	,	,	O
O	806	814	dominant	dominant	JJ	B-NP
O	814	815	-	-	HYPH	I-NP
O	815	823	negative	negative	JJ	I-NP
O	824	834	inhibition	inhibition	NN	I-NP
O	835	837	of	of	IN	B-PP
O	838	842	Mitf	Mitf	NNP	B-NP
O	843	851	resulted	result	VBD	B-VP
O	852	854	in	in	IN	B-PP
O	855	863	profound	profound	JJ	B-NP
O	864	874	resistance	resistance	NN	I-NP
O	875	877	of	of	IN	B-PP
B-Cell	878	889	melanocytes	melanocyte	NNS	B-NP
O	890	893	and	and	CC	O
B-Cell	894	902	melanoma	melanoma	NN	B-NP
I-Cell	903	908	cells	cell	NNS	I-NP
O	909	911	to	to	TO	B-PP
O	912	915	HGF	HGF	NN	B-NP
O	915	916	-	-	HYPH	B-NP
O	916	925	dependent	dependent	JJ	I-NP
B-Cellular_component	926	932	matrix	matrix	NN	I-NP
O	933	941	invasion	invasion	NN	I-NP
O	941	942	,	,	,	O
O	943	953	suggesting	suggest	VBG	B-VP
O	954	955	a	a	DT	B-NP
O	956	967	physiologic	physiologic	JJ	I-NP
O	968	972	role	role	NN	I-NP
O	973	976	for	for	IN	B-PP
O	977	981	this	this	DT	B-NP
O	982	989	pathway	pathway	NN	I-NP
O	990	992	in	in	IN	B-PP
B-Cell	993	1004	melanocytic	melanocytic	JJ	B-NP
O	1005	1016	development	development	NN	I-NP
O	1017	1020	and	and	CC	I-NP
B-Cancer	1021	1029	melanoma	melanoma	NN	I-NP
O	1029	1030	.	.	.	O

